13th Aug 2019 10:20
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Khalid Nabilsi
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Khalid Nabilsi |
2 | Reason for the notification | |
a) | Position/status | Chief Financial Officer |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Disposal of 45,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. |
c) | Price(s) and volume(s) | Price(s): £19.48 Volume(s): 10,000 Price(s): £19.50 Volume(s): 5,000 Price(s): £19.79 Volume(s): 25,000 Price(s): £19.75 Volume(s): 5,000 |
d) | Aggregated information | Aggregated volume: 45,000 Price: £19.68 Total: £885,600 |
e) | Date of the transaction | 9 and 12 August 2019 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Bassam Kanaan
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Bassam Kanaan |
2 | Reason for the notification | |
a) | Position/status | EVP, Corporate Development and M&A |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Disposal of 84,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. |
c) | Price(s) and volume(s) | Price(s): £19.47 Volume(s): 15,000 Price(s): £19.72 Volume(s): 50,000 Price(s): £19.79 Volume(s): 5,000 Price(s): £19.72 Volume(s): 4,500 Price(s): £19.75 Volume(s): 5,000 Price(s): £19.70 Volume(s): 5,000 |
d) | Aggregated information | Aggregated volume: 84,500 Price: £19.68 Total: £1,662,990 |
e) | Date of the transaction | 9 and 12 August 2019 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Peter Speirs, Company Secretary, Responsible for releasing this announcement
13 August 2019
Related Shares:
Hikma Pharmaceuticals